Isomorphic Labs Raises $5 Billion to Accelerate AI-Driven Drug Discovery

Isomorphic Labs, an artificial intelligence drug discovery startup founded by former Google DeepMind CEO Demis Hassabis, has secured $5 billion in a Series C funding round. The investment was co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz and Alphabet (Google's parent company). This follows a previous $2.1 billion Series B round raised in May. The capital is earmarked for developing foundational biology models and advancing the company's therapeutic candidate pipeline toward clinical trials. The funding comes amid a massive surge in sector-wide investment, with drug discovery startups raising a record $23.2 billion in 2026 as major players like OpenAI and Anthropic also pivot toward medical AI applications.

By Kai Nicol-Schwarz · CNBC ·

Isomorphic Labs Raises $5 Billion to Accelerate AI-Driven Drug Discovery

Tickers: $GOOGL

Topics: AI drug discovery Artificial Intelligence Biotechnology Series C funding

Read the full article at CNBC

More World news